LIFE of SCI
0563.547.828 · rovalta.com · 21/09/2026
LIFE of SCI
Overview
What does LIFE of SCI do?
LIFE of SCI is a Private limited company incorporated in 2014. Its main activity is: Management consultancy activities. Its registered office is in Mechelen.
2800 Mechelen · FlandreSee on map
Trend over 11 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||||||||||||
| Gross margin | 199,7 k € | -25.4% | 267,7 k € | +75.0% | 152,9 k € | -61.7% | 398,9 k € | +51.1% | 264 k € | +27.8% | 206,6 k € | +63.4% | 126,4 k € | -18.2% | 154,5 k € | -20.8% | 195,1 k € | +49.1% | 130,9 k € | -29.5% | 185,8 k € |
| EBITDA | 197,7 k € | -25.8% | 266,6 k € | +76.3% | 151,2 k € | -61.9% | 397,2 k € | +51.5% | 262,3 k € | +28.3% | 204,3 k € | +63.2% | 125,2 k € | -18.6% | 153,9 k € | -20.9% | 194,6 k € | +48.8% | 130,7 k € | -29.6% | 185,6 k € |
| Operating result | 188,4 k € | -26.6% | 256,7 k € | +79.1% | 143,3 k € | -63.4% | 391,5 k € | +51.6% | 258,2 k € | +28.8% | 200,5 k € | +65.2% | 121,4 k € | -19.5% | 150,9 k € | -21.5% | 192,2 k € | +47.6% | 130,2 k € | -29.6% | 184,8 k € |
| Net result | 143,9 k € | -26.2% | 194,8 k € | +77.9% | 109,5 k € | -63.3% | 298,5 k € | +51.6% | 196,9 k € | +30.0% | 151,5 k € | +64.0% | 92,4 k € | -19.1% | 114,2 k € | -10.7% | 127,8 k € | +45.1% | 88,1 k € | -28.4% | 123 k € |
| Balance sheet | |||||||||||||||||||||
| Equity | 29,3 k € | -58.4% | 70,5 k € | +244% | 20,5 k € | -71.0% | 70,5 k € | +244% | 20,5 k € | 0.0% | 20,5 k € | 0.0% | 20,5 k € | +154% | 8,1 k € | -97.7% | 345,2 k € | +58.8% | 217,3 k € | +68.2% | 129,2 k € |
| Total assets | 521,4 k € | +29.2% | 403,7 k € | -3.8% | 419,4 k € | -10.6% | 469,4 k € | +11.5% | 421 k € | +35.1% | 311,6 k € | +74.9% | 178,2 k € | -66.2% | 526,7 k € | +9.3% | 482,1 k € | +45.6% | 331,1 k € | +69.0% | 196 k € |
| Cash | 383,5 k € | +57.6% | 243,3 k € | +22.0% | 199,4 k € | -44.0% | 356,2 k € | +9.5% | 325,2 k € | +58.3% | 205,4 k € | +119% | 93,6 k € | -79.0% | 446,3 k € | +13.9% | 391,7 k € | +24.0% | 315,8 k € | +83.3% | 172,3 k € |
| Debts | 492,1 k € | +47.7% | 333,2 k € | -16.5% | 399 k € | +0.0% | 398,9 k € | -0.4% | 400,5 k € | +37.6% | 291,1 k € | +84.6% | 157,7 k € | -69.6% | 518,7 k € | +279% | 136,8 k € | +20.4% | 113,7 k € | +70.4% | 66,7 k € |
Indicative valuation
As an indication, this company is worth
Board of directors
Seen on filing of 31/12/2025 · 1 active · 1 ended
Active mandates
Ended mandates
Other companies at this address
| Company | CBE no. |
|---|---|
Invigo Therapeutics● Active | 0789.481.317 |
Financials
Full financial information
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 09/06/2026 | 01/07/2025 | 30/07/2024 | 05/07/2023 | 19/07/2022 | 31/08/2021 |
| General meeting | 26/05/2026 | 01/06/2025 | 30/06/2024 | 30/06/2023 | 30/06/2022 | 24/08/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Looking for more information about this company?
Try for 7 daysAnnual accounts filings
11 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2025 | 26/05/2026 | 09/06/2026 | Dutch | |
| Micro model | 31/12/2024 | 01/06/2025 | 01/07/2025 | Dutch | |
| Micro model | 31/12/2023 | 30/06/2024 | 30/07/2024 | Dutch | |
| Micro model | 31/12/2022 | 30/06/2023 | 05/07/2023 | Dutch | |
| Micro model | 31/12/2021 | 30/06/2022 | 19/07/2022 | Dutch | |
| Micro model | 31/12/2020 | 24/08/2021 | 31/08/2021 | Dutch | |
| Micro model | 31/12/2019 | 07/09/2020 | 30/09/2020 | Dutch | |
| Micro model | 31/12/2018 | 27/05/2019 | 28/05/2019 | Dutch | |
| Micro model | 31/12/2017 | 28/06/2018 | 26/07/2018 | Dutch | |
| Micro model | 31/12/2016 | 01/06/2017 | 11/07/2017 | Dutch | |
| Abridged model | 31/12/2015 | 29/06/2016 | 29/09/2016 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 1 M€ and 2,5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Seen on filing of 31/12/2025 · 1 active · 1 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
Source: Belgian Official Gazette
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025143,9 k €↓
- 2024Annual accounts 2024194,8 k €↑
- 2023Annual accounts 2023109,5 k €↓
- 2023Name changeLIFE of SCI
- 2022Annual accounts 2022298,5 k €↑
- 2021Annual accounts 2021196,9 k €↑
- 2021Name changeDM&S consulting
- 2020Annual accounts 2020151,5 k €↑
- 2019Annual accounts 201992,4 k €↓
- 2018Annual accounts 2018114,2 k €↓
- 2017Annual accounts 2017127,8 k €↑
- 2016Annual accounts 201688,1 k €↓
- 2015Annual accounts 2015123 k €
- 19/09/2014IncorporationPrivate limited company